Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1999 3
2000 3
2001 4
2002 5
2003 7
2004 2
2005 1
2006 7
2007 5
2008 4
2009 2
2010 7
2011 9
2012 5
2013 1
2014 5
2015 8
2016 12
2017 7
2018 4
2019 8
2020 11
2021 11
2022 17
2023 12
2024 14
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

168 results

Results by year

Filters applied: . Clear all
Page 1
WHO global research priorities for antimicrobial resistance in human health.
Bertagnolio S, Dobreva Z, Centner CM, Olaru ID, Donà D, Burzo S, Huttner BD, Chaillon A, Gebreselassie N, Wi T, Hasso-Agopsowicz M, Allegranzi B, Sati H, Ivanovska V, Kothari KU, Balkhy HH, Cassini A, Hamers RL, Weezenbeek KV; WHO Research Agenda for AMR in Human Health Collaborators. Bertagnolio S, et al. Lancet Microbe. 2024 Nov;5(11):100902. doi: 10.1016/S2666-5247(24)00134-4. Epub 2024 Aug 13. Lancet Microbe. 2024. PMID: 39146948 Free PMC article. Review.
Elevated mortality after successful tuberculosis treatment.
van den Hof S, Borgdorff MW. van den Hof S, et al. Int J Tuberc Lung Dis. 2016 Jan;20(1):2. doi: 10.5588/ijtld.15.0652. Int J Tuberc Lung Dis. 2016. PMID: 26688521 Free PMC article. No abstract available.
Scientific advisory councils in the COVID-19 response.
Delfraissy JF, Horgan M, Mølbak K, Simón FS, Stadler T, van Dissel J, Van Gucht S, Ricciardi W, Wieler L, Vallance P; Covid-19 National Scientific Advisory Councils: Presidents or Representatives. Delfraissy JF, et al. Lancet. 2024 Feb 10;403(10426):510-512. doi: 10.1016/S0140-6736(23)01846-9. Epub 2023 Oct 12. Lancet. 2024. PMID: 37839418 No abstract available.
Effectiveness of Omicron XBB.1.5 vaccine against infection with SARS-CoV-2 Omicron XBB and JN.1 variants, prospective cohort study, the Netherlands, October 2023 to January 2024.
Huiberts AJ, Hoeve CE, de Gier B, Cremer J, van der Veer B, de Melker HE, van de Wijgert JH, van den Hof S, Eggink D, Knol MJ. Huiberts AJ, et al. Among authors: van den hof s. Euro Surveill. 2024 Mar;29(10):2400109. doi: 10.2807/1560-7917.ES.2024.29.10.2400109. Euro Surveill. 2024. PMID: 38456217 Free PMC article.
Transmissibility of SARS-CoV-2 among fully vaccinated individuals.
Knol MJ, Backer JA, de Melker HE, van den Hof S, Gier B. Knol MJ, et al. Among authors: van den hof s. Lancet Infect Dis. 2022 Jan;22(1):16-17. doi: 10.1016/S1473-3099(21)00763-5. Lancet Infect Dis. 2022. PMID: 34953541 Free PMC article. No abstract available.
Programmatic Management of Drug-Resistant Tuberculosis: An Updated Research Agenda.
Mitnick CD, Rodriguez CA, Hatton ML, Brigden G, Cobelens F, Grobusch MP, Horsburgh R, Lange C, Lienhardt C, Oren E, Podewils LJ, Seaworth B, van den Hof S, Daley CL, Gebhard AC, Wares F; RESIST-TB (Research Excellence to Stop TB Resistance) and GDI (Global Drug Resistant TB Initiative). Mitnick CD, et al. Among authors: van den hof s. PLoS One. 2016 May 25;11(5):e0155968. doi: 10.1371/journal.pone.0155968. eCollection 2016. PLoS One. 2016. PMID: 27223622 Free PMC article. Review.
Evidence-based interventions to reduce tuberculosis stigma: a systematic review.
Sommerland N, Wouters E, Mitchell EMH, Ngicho M, Redwood L, Masquillier C, van Hoorn R, van den Hof S, Van Rie A. Sommerland N, et al. Among authors: van den hof s. Int J Tuberc Lung Dis. 2017 Nov 1;21(11):81-86. doi: 10.5588/ijtld.16.0788. Int J Tuberc Lung Dis. 2017. PMID: 29025489 Review.
Integration of drug safety monitoring in tuberculosis treatment programmes: country experiences.
Tiemersma E, van den Hof S, Dravniece G, Wares F, Molla Y, Permata Y, Lukitosari E, Quelapio M, Aung ST, Aung KM, Thuy HT, Hoa VD, Sulaimanova M, Sagyndikova S, Makhmudova M, Soliev A, Kimerling M. Tiemersma E, et al. Among authors: van den hof s. Eur Respir Rev. 2019 Oct 11;28(153):180115. doi: 10.1183/16000617.0115-2018. Print 2019 Sep 30. Eur Respir Rev. 2019. PMID: 31604816 Free PMC article. Review.
168 results